Pharmacokinetic characterization of recombinant factor XIII (FXIII)‐A2 across age groups in patients with FXIII A‐subunit congenital deficiency

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|3|380-385

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.3, 2015-05, pp. : 380-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐factor XIII A subunit (FXIII‐A) autoantibodies block FXIII‐A2B2 assembly and steal FXIII‐A from native FXIII‐A2B2

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 802-814

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor XIII (FXIII) and angiogenesis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 19-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Coagulation Factor XIII (FXIII) in Angiogenesis and Tissue Repair

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 162-165

Karger

Access to resources Recommend Favorite

Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy

By Hanna Jennifer   Winstedt Dag   Schött Ulf  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 7, 2013-10 ,pp. : 553-562

Informa Healthcare

Access to resources Recommend Favorite

Congenital Factor V Deficiency: Comparison of the Severity of Clinical Presentations among Patients with Rare Bleeding Disorders

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-09 ,pp. : 148-154

Karger

Access to resources Recommend Favorite